Stock Price
13.24
Daily Change
0.10 0.76%
Monthly
-3.89%
Yearly
-47.52%
Q1 Forecast
12.83



Peers Price Chg Day Year Date
Amplifon 13.24 0.10 0.76% -47.52% Feb/20
Avanos Medical 15.46 0.25 1.64% 0.06% Feb/20
Brookdale Senior Living 14.90 -0.05 -0.33% 173.39% Feb/20
Cencora 361.08 1.97 0.55% 49.56% Feb/20
Diasorin 70.22 1.12 1.62% -29.43% Feb/20
Encompass Health 106.55 -0.60 -0.56% 6.67% Feb/20
Enovis 22.73 0.43 1.93% -48.22% Feb/20
GE HealthCare Technologies 84.23 1.22 1.47% -7.53% Feb/20
Pediatrix Medical Group 18.82 -0.48 -2.49% -12.34% Feb/20
Veradigm 4.31 -0.19 -4.22% -15.49% Feb/20

Indexes Price Day Year Date
IT40 46473 678.75 1.48% 20.96% Feb/20
EU600 631 5.23 0.84% 13.85% Feb/20

Amplifon traded at 13.24 this Friday February 20th, increasing 0.10 or 0.76 percent since the previous trading session. Looking back, over the last four weeks, Amplifon gained 3.89 percent. Over the last 12 months, its price fell by 47.52 percent. Looking ahead, we forecast Amplifon to be priced at 12.83 by the end of this quarter and at 11.69 in one year, according to Trading Economics global macro models projections and analysts expectations.

Amplifon SpA is an Italy-based company active in the hearing care retail market. The Company provides personalized solutions and customer care to hearing-impaired people. It offers a wide range of services from diagnosing hearing difficulties, to fitting, servicing and maintaining hearing aids. The Company is organized in three geographical operating segments: Europe, Middle East and Africa - EMEA - (Italy, France, The Netherlands, Germany, the United Kingdom, Ireland, Spain, Portugal, Switzerland, Belgium, Luxemburg, Hungary, Egypt, Turkey, Poland and Israel), Americas (USA, Canada, Chile, Argentina, Ecuador, Colombia, Panama and Mexico) and Asia-Pacific (Australia, New Zealand, India and China).